Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa carrying blaVIM-2 in burn wards, China

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 5, 2011, Pages 505-506

  Zhang, Ruowen ^a   Mingcheng, Li ^b   Dong, Xueyan ^a   Li, Fan ^a  

^a Basic Medical College   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENOMIC DNA; GENTAMICIN; IMIPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE VIM 2; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; BLA IMP GENE; BLA VIM 2 GENE; BLOOD CULTURE; BURN CULTURE; BURN UNIT; CHILD; CHINA; CONTROLLED STUDY; DISK DIFFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME SYNTHESIS; EPIDEMIC; GENE CASSETTE; HOSPITAL INFECTION; HUMAN; LETTER; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE ORGAN FAILURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; SEPSIS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BURNS; CARBAPENEMS; CHILD; CHINA; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 82855169513     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70241-0     Document Type: Letter

References (7)

1. Clinical and Laboratory Standards Institute, 2005. Performance Standards for Antimicrobial Susceptibility Testing; 15 th information supplement. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Kim I.S., Lee N.Y., Ki C.S., et al. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-β-lactamase actamaseproducers in a Korean hospital. Microb Drug Resist 2005, 11:355-359.
3. Vurma-Rapp U., Kayser F.H., Hadorn K., Wiederkehr F. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy. Eur J Clin Microbiol Infect Dis 1990, 9(8):580-587.
4. Gales A.C., Torres P.L., Vilarinho D.S., et al. Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital. Braz J Infect Dis 2004, 8(4):267-271.
5. Dong F., Yu Y.S., Qu T.T., et al. Integron containing the VIM-2 metallo-β-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals. J Clin Microbiol 2006, 44:4242-4245.
6. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):410-419.
7. Crespo M.P., Woodford N., Sinclair A., et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 2004, 42(11):5094-5101.